Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry
Kidney News · 07.08.2026 · 18 (8) · 26-27
DOI: 10.62716/kn.004202026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney News, erschienen am 07.08.2026. Verfasst von Melissa West. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Twice a year, Kidney News publishes a high-level review of US Food and Drug Administration (FDA) regulatory approvals, scientific results from industry, investments, and mergers and acquisitions to ensure the ASN membership is well-informed. More than 500 data points, collected from January 1 to June 30, 2026, generated the following analyses and summaries.
Zitieren
APA
West, M. (2026). Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry. Kidney News, 18(8), 26-27. https://doi.org/10.62716/kn.004202026
Vancouver
West M. Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry. Kidney News. 2026;18(8):26-27. doi:10.62716/kn.004202026
BibTeX
@article{West2026,
author = {West, Melissa},
title = {Business Round-Up: Q1–Q2 2026 Activity in the Nephrology Industry},
journal = {Kidney News},
year = {2026},
volume = {18},
number = {8},
pages = {26--27},
doi = {10.62716/kn.004202026}
}
EUVIMED